Related references
Note: Only part of the references are listed.Autophagy promotes BrafV600E-driven lung tumorigenesis by preserving mitochondrial metabolism
Anne M. Strohecker et al.
AUTOPHAGY (2014)
Targeting ER stress-induced autophagy overcomes BRAF inhibitor resistance in melanoma
Xiao-Hong Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Autophagy Inhibition Improves Chemosensitivity in BRAFV600E Brain Tumors
Jean M. Mulcahy Levy et al.
CANCER DISCOVERY (2014)
Autophagy-Dependent Production of Secreted Factors Facilitates Oncogenic RAS-Driven Invasion
Rebecca Lock et al.
CANCER DISCOVERY (2014)
Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
Michael Cerezo et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Autophagy Sustains Mitochondrial Glutamine Metabolism and Growth of BrafV600E-Driven Lung Tumors
Anne M. Strohecker et al.
CANCER DISCOVERY (2013)
Guidelines for the use and interpretation of assays for monitoring autophagy
Daniel J. Klionsky et al.
AUTOPHAGY (2012)
Relationship between 18F-Fluorodeoxyglucose Accumulation and KRAS/BRAF Mutations in Colorectal Cancer
Kenji Kawada et al.
CLINICAL CANCER RESEARCH (2012)
Marked, Homogeneous, and Early [18F]Fluorodeoxyglucose-Positron Emission Tomography Responses to Vemurafenib in BRAF-Mutant Advanced Melanoma
Grant A. McArthur et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway
Carlotta Petti et al.
MELANOMA RESEARCH (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR
Daniel F. Egan et al.
AUTOPHAGY (2011)
Combinatorial Treatments That Overcome PDGFRβ-Driven Resistance of Melanoma Cells to V600EB-RAF Inhibition
Hubing Shi et al.
CANCER RESEARCH (2011)
Regulation of the autophagy initiating kinase ULK1 by nutrients Roles of mTORC1 and AMPK
Joungmok Kim et al.
CELL CYCLE (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2011)
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
Nikhil Wagle et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Narrative Review: BRAF Opens the Door for Therapeutic Advances in Melanoma
Keith T. Flaherty
ANNALS OF INTERNAL MEDICINE (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
Zhijun Luo et al.
FUTURE ONCOLOGY (2010)
Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032
Jonas N. Sondergaard et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M. Johannessen et al.
NATURE (2010)
Melanomas acquire resistance toB-RAF(V600E) inhibition by RTK or N-RAS upregulation
Ramin Nazarian et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
Ruth Halaban et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
Oncogenic B-RAF Negatively Regulates the Tumor Suppressor LKB1 to Promote Melanoma Cell Proliferation
Bin Zheng et al.
MOLECULAR CELL (2009)
Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma
Clara Montagut et al.
CANCER RESEARCH (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Necrotic tumor cell death in vivo impairs tumor-specific immune responses
Jaba Gamrekelashvili et al.
JOURNAL OF IMMUNOLOGY (2007)
CellProfiler: image analysis software for identifying and quantifying cell phenotypes
Anne E. Carpenter et al.
GENOME BIOLOGY (2006)
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation
PB Gupta et al.
NATURE GENETICS (2005)
Autophagy in metazoans: Cell survival in the land of plenty
JJ Lum et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Development by self-digestion: Molecular mechanisms and biological functions of autophagy
B Levine et al.
DEVELOPMENTAL CELL (2004)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
L Johnson et al.
NATURE (2001)
Molecular dissection of autophagy: Two ubiquitin-like systems
Y Ohsumi
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
